Skip to main content
Log in

Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The degree of immunomodulation by perioperative blood transfusion and its resultant effects on cancer surgery are a subject of controversy. We evaluated the prognostic effects of perioperative blood transfusion on gastric cancer surgery.

Methods: A total of 1710 patients who underwent curative gastrectomy for gastric cancer from 1991 to 1995 were retrospectively reviewed. Uni- and multivariate analyses of the incidence, amount, and timing of perioperative blood transfusions and a comparison of the clinicopathological features were performed.

Results: A higher incidence of blood transfusions was associated with female sex, large tumors, upper-body location, Borrmann type III or IV lesions, longer operations, total gastrectomies, splenectomies, and D3 or more extended lymphadenectomy. The tumors in the transfused group were more advanced in depth of invasion and nodal classification. More frequent tumor recurrences were found in the transfused group. A dose-response relationship between the amount of transfused blood and prognosis was evident. Subgroup analyses of prognosis according to stage showed significant differences in stages III and IV between the transfused and nontransfused groups. On multivariate analysis, transfusion was shown to be an independent risk factor for recurrence and poor prognosis.

Conclusions: These results suggest that perioperative transfusion is an unfavorable prognostic factor. It is thus better to refrain from unnecessary blood transfusion and to give the least amount of blood to patients with gastric cancer when transfusion is inevitable, especially for those with stage III and IV gastric cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. George CD, Morello PJ. The immunological effects of blood transfusion on renal transplants, tumor operations and bacterial infections.Am J Surg 1986;152:329–37.

    Article  PubMed  CAS  Google Scholar 

  2. Kerman RH, van Buren CT, Flechner S, et al. Influence of blood transfusions on immune responsiveness.Transplant Proc 1982;14:335–7.

    PubMed  CAS  Google Scholar 

  3. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions.N Engl J Med 1978;299:799–803.

    PubMed  CAS  Google Scholar 

  4. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.Surgery 1994;115:303–9.

    PubMed  CAS  Google Scholar 

  5. Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr. Perioperative blood transfusion has prognostic significance for breast cancer.Surgery 1985;97:225–30.

    PubMed  CAS  Google Scholar 

  6. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck.Arch Otolaryngol Head Neck Surg 1990;116:304–9.

    PubMed  CAS  Google Scholar 

  7. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection.Am J Surg 1985;149:502–7.

    Article  PubMed  CAS  Google Scholar 

  8. Rosenberg SA, Seipp CA, White DE, Wesley R. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities.J Clin Oncol 1985;3:698–709.

    PubMed  CAS  Google Scholar 

  9. Chesi R, Cazzola A, Bacci G, Borghi B, Balladelli A, Urso G. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy.Cancer 1989;64:1727–37.

    Article  PubMed  CAS  Google Scholar 

  10. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival.Am J Surg 1988;156:374–80.

    Article  PubMed  CAS  Google Scholar 

  11. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation.Anesth Analg 1996;82:187–204.

    Article  PubMed  CAS  Google Scholar 

  12. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma.Br J Surg 1993;80:427–32.

    Article  PubMed  CAS  Google Scholar 

  13. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis.Transfusion 1993;33:754–65.

    Article  PubMed  CAS  Google Scholar 

  14. Sugezawa A, Kaibara N, Sumi K, et al. Blood transfusion and the prognosis of patients with gastric cancer.J Surg Oncol 1989;42:113–6.

    Article  PubMed  CAS  Google Scholar 

  15. Maeta M, Shimizu N, Oka A, et al. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer.J Surg Oncol 1994;55:149–53.

    Article  PubMed  CAS  Google Scholar 

  16. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma.Am J Surg 1994;167:256–60.

    Article  PubMed  CAS  Google Scholar 

  17. Kampschoer GH, Maruyama K, Sasako M, Kinoshita T, van de Velde CJ. The effects of blood transfusion on the prognosis of patients with gastric cancer.World J Surg 1989;13:637–43.

    Article  PubMed  CAS  Google Scholar 

  18. Kaneda M, Horimi T, Ninomiya M, et al. Adverse affect of blood transfusions on survival of patients with gastric cancer.Transfusion 1987;27:375–7.

    Article  PubMed  CAS  Google Scholar 

  19. Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Abad JM, et al. Does perioperative blood transfusion influence long-term prognosis of gastric cancer?Dig Dis Sci 1997;42:2072–6.

    Article  PubMed  CAS  Google Scholar 

  20. Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer.Cancer 1990;66:2331–5.

    Article  PubMed  CAS  Google Scholar 

  21. Sobin LH, Wittekind C.International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997:59–62.

    Google Scholar 

  22. Nishi M, Omori Y, Miwa K.Japanese Research Society for Gastric Cancer (JRSGC). Japanese Classification of Gastric Carcinoma. 1st English ed. Tokyo: Kanehara, 1995:6–15.

    Google Scholar 

  23. Norusis MJ.SPSS 9.0 Guide to Data Analysis. Englewood Cliffs, NJ: Prentice Hall, 1998.

    Google Scholar 

  24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.

    Article  Google Scholar 

  25. Cox DR. Regression models and life tables.J R Stat Soc 1972;34:187–220.

    Google Scholar 

  26. Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence.J Clin Oncol 1988;6:1348–54.

    PubMed  CAS  Google Scholar 

  27. Busch ORC, Hop WCJ, van Papendrecht MAWH, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer.N Engl J Med 1993;328:1372–6.

    Article  PubMed  CAS  Google Scholar 

  28. Heiss MM, Allgayer H, Gruetzner KU, et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients.Anticancer Res 1997;17:2657–61.

    PubMed  CAS  Google Scholar 

  29. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma.Br J Surg 2000;87:236–42.

    Article  PubMed  CAS  Google Scholar 

  30. Park CH, Byun JY, Kim BK, Kim IC. Recurrent gastric cancer after curative surgery.J Korean Cancer Assoc 1998;30:488–96.

    Google Scholar 

  31. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery—prospective double-blind placebo-controlled study.World J Surg 1999;23:30–5.

    Article  PubMed  CAS  Google Scholar 

  32. Winslow RM. New transfusion strategies: red cell substitutes.Annu Rev Med 1999;50:337–53.

    Article  PubMed  CAS  Google Scholar 

  33. Hochberg J, Murray GF. Principles of operative surgery. In: Sabiston DC Jr, Lyerly HK, eds.Textbook of Surgery, 15th ed. Philadelphia: WB Saunders, 1997:253–63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sung Hoon Noh MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyung, W.J., Noh, S.H., Shin, D.W. et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9, 5–12 (2002). https://doi.org/10.1245/aso.2002.9.1.5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/aso.2002.9.1.5

Key Words

Navigation